Retrospective Cohort Study
Copyright ©The Author(s) 2015.
World J Gastroenterol. Jun 28, 2015; 21(24): 7488-7494
Published online Jun 28, 2015. doi: 10.3748/wjg.v21.i24.7488
Table 2 Multivariate analysis of risk factors related to survival in patients with hepatocellular carcinoma rupture
VariablesHR95%CIP value
Age (yr)0.960.93-1.000.026
Lesion length (cm)1.461.23-1.73< 0.001
Number1.371.01-1.850.042
Cirrhosis (presence)2.470.77-7.960.131
BCLC stage A (control)---
BCLC stage B0.100.02-0.410.002
BCLC stage C0.190.03-1.010.052
Treatment before rupture (presence)4.361.27-14.990.019
Treatment in follow-up period (presence)0.210.07-0.670.008
WBC, × 109/L1.040.96-1.130.375
HB, g/L0.990.97-1.000.314
PLT, × 1010/L1.000.99-1.000.143
INR0.390.04-3.600.406
APTT, S1.070.99-1.150.103
ALT, U/L1.001.00-1.010.011
ALB, g/L0.890.81-0.970.010
TBil, umol/L1.000.97-1.020.735
HCO3-, mmol/L1.181.08-1.28< 0.001
Crea, umol/L1.011.00-1.020.089
Child-Pugh1.030.59-1.800.905